Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
Cancer immunotherapy has been the focus of intense research since the late 19th century when Coley observed that bacterial components can contribute to cancer regression by eliciting an antitumor immune response. Successful activation and maturation of tumor-specific immune cells is now known to be...
Saved in:
Main Authors: | Alja Oblak, Roman Jerala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/609579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
by: Lili Yu, et al.
Published: (2018-01-01) -
Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy
by: Hui Wang, et al.
Published: (2014-01-01) -
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
by: Saghar Pahlavanneshan, et al.
Published: (2021-01-01) -
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
by: Monica Molteni, et al.
Published: (2016-01-01) -
Toll-like receptor 4 pathway evolutionary trajectory and functional emergence
by: Shailya Verma, et al.
Published: (2025-01-01)